Oldenborg Sabine, Valk Christel, van Os Rob, Oei Bing, Venselaar Jack, Vörding Paul Zum Vörde Sive, van Randen Adriënne, Crezee Hans, van Tienhoven Geertjan, Rasch Coen
Department of Radiation Oncology, Z1-215, Academic Medical Center, University of Amsterdam, Meibergdreef 9, P.O. Box 22660, Amsterdam, The Netherlands.
Institute Verbeeten (BVI), Tilburg, The Netherlands.
Strahlenther Onkol. 2016 Apr;192(4):240-7. doi: 10.1007/s00066-016-0946-3. Epub 2016 Feb 8.
Combining reirradiation (reRT) and hyperthermia (HT) has shown high therapeutic value for patients with locoregional recurrent breast cancer (LR). However, additional toxicity of reirradiation (e.g., rib fractures) may occur. The aim of this study is to determine the impact of potential risk factors on the occurrence of rib fractures.
From 1982-2005, 234 patients were treated with adjuvant reRT + HT after surgery for LR. ReRT consisted typically of 8 fractions of 4 Gy twice a week, or 12 fractions of 3 Gy four times a week. A total of 118 patients were irradiated with abutted photon and electron fields. In all, 60 patients were irradiated using either one or alternating combinations of abutted AP electron fields. Hyperthermia was given once or twice a week.
The 5-year infield local control (LC) rate was 70 %. Rib fractures were detected in 16 of 234 patients (actuarial risk: 7 % at 5 years). All rib fractures occurred in patients treated with a combination of photon and abutted electron fields (p = 0.000); in 15 of 16 patients fractures were located in the abutment regions. The other significant predictive factors for rib fractures were a higher fraction dose (p = 0.040), large RT fields, and treatment before the year 2000.
ReRT + HT results in long-term LC. The majority of rib fractures were located in the photon/electron abutment area, emphasizing the disadvantage of field overlap. Large abutted photon/electron fields combined with 4 Gy fractions increase the number of rib fractures in this study group. However, as these factors were highly correlated no relative importance of the individual factors could be estimated. Increasing the number of HT sessions a week does not increase the risk of rib fractures.
再程放疗(reRT)联合热疗(HT)对局部区域复发性乳腺癌(LR)患者显示出较高的治疗价值。然而,再程放疗可能会出现额外的毒性反应(如肋骨骨折)。本研究的目的是确定潜在风险因素对肋骨骨折发生的影响。
1982年至2005年期间,234例LR患者术后接受辅助性再程放疗+热疗。再程放疗通常为每周两次,每次4 Gy,共8次分割;或每周4次,每次3 Gy,共12次分割。共有118例患者接受相邻光子和电子野照射。总计60例患者使用相邻前后位电子野的单一野或交替组合野照射。热疗每周进行1次或2次。
5年内野内局部控制(LC)率为70%。234例患者中有16例发生肋骨骨折(5年精算风险:7%)。所有肋骨骨折均发生在接受光子野与相邻电子野联合治疗的患者中(p = 0.000);16例患者中有15例骨折位于相邻区域。肋骨骨折的其他重要预测因素包括较高的分次剂量(p = 0.040)、较大的放疗野以及2000年前接受治疗。
再程放疗+热疗可实现长期局部控制。大多数肋骨骨折位于光子/电子野相邻区域,凸显了野重叠的弊端。在本研究组中,较大的相邻光子/电子野联合4 Gy分次剂量会增加肋骨骨折的数量。然而,由于这些因素高度相关,无法估计各因素的相对重要性。每周增加热疗次数不会增加肋骨骨折风险。